Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
17M
-
Shares change
-
+5.3M
-
Total reported value, excl. options
-
$310M
-
Value change
-
+$96.7M
-
Put/Call ratio
-
1.44
-
Number of buys
-
63
-
Number of sells
-
-37
-
Price
-
$18.39
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q1 2017
136 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2017.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17M shares
of 54.8M outstanding shares and own 31.03% of the company stock.
Largest 10 shareholders include RHO CAPITAL PARTNERS INC (3.57M shares), BlackRock Inc. (1.41M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1M shares), VANGUARD GROUP INC (944K shares), FMR LLC (939K shares), Chescapmanager LLC (893K shares), DISCIPLINED GROWTH INVESTORS INC /MN (877K shares), FRANKLIN RESOURCES INC (592K shares), STATE STREET CORP (413K shares), and Opaleye Management Inc. (385K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.